NCI Resources

NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - October 2001 Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - September 2001 Table of ContentsThe association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.An intronic variant in PTEN is not associated with prostate cancer risk.Clinical and experimental...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - October 2001 Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group. Androgen blockade in prostate cancer. Biochemical course after radical retropubic prostatectomy:...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - September 2001 Table of ContentsEffect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men.Treatment of prostate cancer--any news?[Anemia and neoadjuvant hormone therapy in radical surgery of localized cancer of the...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - April 2002 [Hormone-resistant epithelial cancer of the prostate] Interleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma Conditional loss of Nkx3.1 in adult mice induces...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - August 2002 Molecular profiling of angiogenesis markers. Inhibition of growth and cell cycle arrest of ARCaP human prostate cancer cells by ectopic expression of ER-alpha. Expression analysis of delta-catenin and prostate-specific membrane antigen:...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - February 2002 Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells. Radiation...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - January 2002 Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the Technology evaluation: CV-787, Calydon Inc. Avoiding tolerance against prostatic antigens with subdominant peptide...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - July 2002 Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells. [Analysis of loss of heterozygosity on chromosome 6 in human prostate carcinoma and prostatic intraepithelial...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - June 2002 Androgen receptor CAG repeats and prostate cancer. Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer. Genome analysis yields mutations linked to hereditary prostate cancer. Knowledge and...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - March 2002 Early reduction in the aneuploidy at chromosomes 7 and 8 are significantly correlated with clinical effect in high-dose rate Hypermethylation of tumor-related genes in genitourinary cancer cell lines. Refined mapping of allele loss at...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - May 2002 Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of Antisense...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - October 2002 Suicide gene therapy for urogenital cancer: current outcome and prospects. Tissue-specific promoters in gene therapy for the treatment of prostate cancer. Human hormone-refractory prostate cancers can harbor mutations in the ...
NCI CANCERLIT^® Search: Prostate Cancer, Hereditary - September 2002 A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes. The effect of a single BRCA2 mutation on cancer in Iceland. Nuclear/Nucleolar morphometry and DNA image cytometry as a combined diagnostic tool...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - April 2002 Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective. [Changes in prostate-specific antigen in casodex (bicalutamide) monotherapy in a dose 150 mg/day given to patients with locally...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - August 2002 Screening for carcinoma of the prostate in a randomly selected population using duplicate digital rectal examination. Eligard. Tiny implant fights prostate cancer. Genistein, a soy isoflavone, induces glutathione peroxidase in the human ...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - February 2002 Radiation therapy for the treatment of locally advanced and metastatic prostate cancer. Prostate cancer gene therapy. Paclitaxel and docetaxel in prostate cancer. Complementary and alternative therapies for advanced prostate cancer. Clinical...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - January 2002 The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate Improved outcomes with radiation for prostate cancer. The impact of docetaxel, estramustine, and low dose hydrocortisone...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - July 2002 Oat-cell carcinoma of the prostate. Diagnosis, prognosis and therapeutic implications. Radical prostatectomy in patients with previous groin hernia repair using synthetic nonabsorbable mesh. Liposome-mediated gene therapy using...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - June 2002 Prostate cancer: natural history and surgical treatment of localised disease. Radiotherapy and combined modality approaches in localised prostate cancer. Systemic treatment and new developments in advanced prostate cancer. Laparoscopic...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - March 2002 Numerical analysis of a model of organ motion using serial imaging measurements from prostate radiotherapy. Rationale for and results of nerve grafting during radical prostatectomy. Nerve grafts are rarely necessary and are unlikely to...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - May 2002 Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. Re: Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - October 2002 Suicide gene therapy for urogenital cancer: current outcome and prospects. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: Epidemiology of...
NCI CANCERLIT^® Search: Therapy of Prostate Cancer - September 2002 Nomograms for clinically localized prostate cancer. Part I: radical prostatectomy. Nomograms for clinically localized prostate cancer. Part II: radiation therapy. Nomograms for clinically localized disease. Part III: watchful waiting. ...
NCI/PDQ^® Health professionals: Extragonadal Germ Cell Tumors Treatment (PDQ®) TABLE OF CONTENTS General Information About Extragonadal Germ Cell TumorsCellular Classification of Extragonadal Germ Cell TumorsGood PrognosisNonseminomaSeminomaIntermediate PrognosisNonseminomaSeminomaPoor PrognosisNonseminomaSeminomaBenign...
NCI/PDQ^® Health professionals: Prostate Cancer Prevention (PDQ®) TABLE OF CONTENTS OverviewBenefits From Finasteride and Dutasteride Chemoprevention Harms From Finasteride and Dutasteride ChemopreventionFinasterideDutasteride Other Prevention InterventionsSignificanceIncidence and MortalityRisk Factors for...
NCI/PDQ^® Health professionals: Prostate Cancer Screening (PDQ®) TABLE OF CONTENTS Summary of EvidenceDigital Rectal Examination and Prostate-Specific AntigenBenefitsHarmsSignificanceIncidence and MortalityRisk FactorsEvidence of BenefitDigital Rectal ExamTransrectal Ultrasound and Other Imaging...
NCI/PDQ^® Health professionals: Prostate Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Prostate Cancer Incidence and MortalityRelated SummariesCellular Classification of Prostate CancerStage Information for Prostate CancerDefinitions of TNMTreatment Option OverviewSurgical...
NCI/PDQ^® Pacientes: Cáncer de la próstata: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de la próstataEstadios del cáncer de próstataCáncer de la próstata recidivanteAspectos generales de las opciones de tratamientoOpciones de tratamiento por...
NCI/PDQ^® Pacientes: Tumores extragonadales de células germinales TABLE OF CONTENTS Información general¿Qué son los tumores extragonadales de células germinales?Modificaciones a este sumario (11/18/2004)Para mayor informaciónDescripción del PDQ® Información general Back...
NCI/PDQ^® Patients: Prostate Cancer Prevention (PDQ®) TABLE OF CONTENTS What is prevention?General Information About Prostate CancerProstate Cancer PreventionChanges to This Summary (05/25/2012)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ® What is prevention? Back...
NCI/PDQ^® Patients: Prostate Cancer Screening (PDQ®) TABLE OF CONTENTS What is screening?General Information About Prostate CancerProstate Cancer ScreeningRisks of Prostate Cancer ScreeningChanges to This Summary (11/02/2012)Questions or Comments About This SummaryGet More Information From NCIAbout...
NCI/PDQ^® Patients: Prostate Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Prostate CancerStages of Prostate CancerRecurrent Prostate CancerTreatment Option OverviewTreatment Options by Stage Stage I Prostate CancerStage II Prostate CancerStage III Prostate CancerStage IV...
NCI/PDQ^® Profesionales De Salud: Cáncer de la próstata: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de próstataIncidencia y mortalidadSumarios relacionadosClasificación celular del cáncer de próstataInformación sobre los estadios del cáncer de...
NCI/PDQ^® Profesionales De Salud: Tumores extragonadales de células germinales: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre los tumores extragonadales de células germinalesClasificación celular de los tumores extragonadales de células germinalesPronóstico favorableNo seminomaSeminoma Pronóstico...